Clinical trial · Observational
Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer
Observational Retrospective Trial on Sequential Hormonal Therapy in Patients
NCT00668083CI-TRIAL-00004182SorsecompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Hormonal sensitivity to second line treatment for CaP after Bicalutamide
- timeFrame
- six months
Secondary outcomes (1)
- measure
- median duration of second and third line treatments;
- timeFrame
- six months
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: * non metastatic Prostate Cancer * previous treatment with bicalutamide 150mg * biochemical relapse/progression Exclusion Criteria: * use of other treatments for Prostate Cancer
References
Publications (0)
Data not yet available
No reference posted for this study.